Three technologies that will shape biotech in 2026

MIT Technology Review has identified three key technologies that will shape biotech in 2026. The first is personalized gene editing, exemplified by the case of KJ Muldoon, who was successfully treated with a personalized gene therapy for a rare genetic disorder. The second technology involves genetic resurrection, with companies like Colossal Biosciences working on bringing back extinct species like the woolly mammoth and dire wolves through ancient DNA analysis and cloning. Lastly, embryo scoring has evolved to allow for the selection of embryos based on traits like height, eye color, and even IQ, raising ethical concerns around eugenics and the complexities of genetic traits.